-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
HIV disproportionately affects men who have sex with men (MSM)
.
Globally, pre-exposure prophylaxis (PrEP) is an evidence-based risk reduction measure that includes initiation of combined tenofovir disoproxil fumarate and emtricitabine before and during HIV exposure in HIV-seronegative individuals , to prevent HIV infection
HIV disproportionately affects men who have sex with men (MSM)
This study evaluated changes in HIV infection events, adherence, safety, and sexual behavior among gay men using daily preventive measures (D-PrEP) and event-driven preventive measures (ED-PrEP) in 4 cities in China
This non-randomized controlled trial was conducted in Beijing, Shenyang, Chongqing, and Shenzhen from December 11, 2018, to November 30, 2020, in HIV-seronegative gay men
.
Participants self-selected the D-PrEP or ED-PrEP regimen at baseline and could switch regimens during the 12-month study period
This non-randomized controlled trial was conducted in Beijing, Shenyang, Chongqing, and Shenzhen from December 11, 2018, to November 30, 2020, in HIV-seronegative gay men
A total of 1530 MSM were included in the analysis
Sexual behavior associated with HIV risk and syphilis incidence during follow-up in pre-exposure prophylaxis (PrEP) users and non-users
Sexual Behaviors Associated with HIV Risk and Syphilis Incidence During Follow-up of Pre-exposure Prophylaxis (PrEP) Users and Non-users Sexual Behaviors Associated with HIV Risk and Syphilis Incidence During Follow-up ofPre-exposure Prophylaxis (PrEP) Users and Non-usersAdherence increased over time among ED-PrEP users and decreased over time among D-PrEP users during the study period .
Daily PrEP users reported fewer adverse events than ED PrEP users .
Adherence increased over time among ED-PrEP users and decreased over time among D-PrEP users during the study period .
Daily PrEP users reported fewer adverse events than ED PrEP users .
Adherence increased over time among ED-PrEP users and decreased over time among D-PrEP users during the study period .
Daily PrEP users reported fewer adverse events than ED PrEP users .
Adherence increased over time among ED-PrEP users and decreased over time among D-PrEP users during the study period .
Daily PrEP users reported fewer adverse events than ED PrEP users .
Adherence increased over time in ED-PrEP users and decreased over time in D-PrEP users
The results of this study showed that both D-PrEP and ED-PrEP regimens were associated with lower HIV incidence and favorable safety profile among high-risk MSM in China
References: Wang H, Wang Z, Huang X, et al.
Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China :A Nonrandomized Controlled Trial .
JAMA Netw Open.
2022;5(2): e2148782.
doi:10.
1001/jamanetworkopen.
2021.
48782 References: Wang H, Wang Z, Huang X, et al.
Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China : A Nonrandomized Controlled Trial .
JAMA Netw Open.
2022 ;5(2):e2148782.
doi :10.
1001/jamanetworkopen.
2021.
48782Wang H, Wang Z, Huang X, et al.
Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China : A Nonrandomized Controlled Trial : .
JAMA Netw Open.
JAMA 2022;5(2):e2148782 .
doi:10.
1001/jamanetworkopen.
2021.
48782 doi:10.
1001/jamanetworkopen.
2021.
48782 Leave a message here